10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,974 | -37.1% | 7,563 | -14.8% | 0.03% | -37.2% |
| Q2 2023 | $495,915 | +17.9% | 8,881 | +17.8% | 0.04% | +10.3% |
| Q1 2023 | $420,601 | +104.6% | 7,539 | +33.6% | 0.04% | +85.7% |
| Q4 2022 | $205,558 | -17.4% | 5,641 | +2.4% | 0.02% | -19.2% |
| Q2 2022 | $249,000 | -15.0% | 5,507 | +42.9% | 0.03% | 0.0% |
| Q1 2022 | $293,000 | +42.9% | 3,854 | +180.5% | 0.03% | +100.0% |
| Q4 2021 | $205,000 | – | 1,374 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |